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1. Introduction
  Bacterial resistance to antimicrobial agents is an out 
growing problem in the treatment of bacterial infections. 
This is due to the alteration of resistance mechanisms, 
acquisition of resistance genetic element from other 
bacteria and genetic changes in bacteria[1,2]. Hence, many 
researchers have been focusing on recognition of resistance 
mechanisms among bacterial isolates.
  Historically, Staphylococcus aureus(S. aureus) has been 
recognized as an important cause of disease around the 
world and it has become a major pathogen associated with 
both hospital- and community-acquired infections. In 
the past, the availability of antibiotics, invasive infections 
caused by S. aureus were often fatal. The introduction 
of penicillin greatly improved the prognosis for patients 
with severe staphylococcal infections, but after a few 
years of clinical use, resistance appeared owing to 
production of 毬-lactamases that hydrolyze the penicillins. 
Therefore, penicillins that were resistant to the action of 
毬-lactamases, such as methicillin, were developed to 
treat staphylococcal infection caused by 毬-lactamase-
producing strains. 
  Methicillin was designed to resist 毬-lactamase 
degradation, but methicillin-resistant Staphylococcus 
aureus (MRSA) strains that were resistant to all 毬 -lactam 
antibiotics were identified soon after methicillin was 
introduced into clinical practice[3]. Although there are three 
known mechanisms for which S. aureus becomes resistant 
to methicillin-hyperproduction of 毬-lactamases[4]; modification 
of normal penicillin-binding proteins (PBPs)[5] and the 
presence of an acquired penicillin-binding protein, PBP2a[6] 
of most clinical isolates present the latter mechanism.
  Until recently, MRSA was predominantly a nosocomial 
pathogen causing hospital-acquired infections, but 
MRSA strains are now being increasingly isolated from 
community-acquired infections as well[7]. Although 
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community-acquired-MRSA (CA-MRSA) strains cause 
mostly skin abscesses and furunculosis, severe necrotizing 
pneumonia and shock resulting in death has also been 
associated with CA-MRSA[8,9]. These new CA-MRSA strains 
are usually resistant to 毬-lactams but susceptible to other 
antimicrobial classes and carry mostly staphylococcal 
cassette chromosome mec (SCCmec) type IV. CA-MRSA 
strains are also more likely to possess unique combinations 
of virulence factors and seem to be genetically different from 
hospital-acquired-MRSA (HA-MRSA)[8-11]. Investigators 
have suggested that CA-MRSA strains have arisen from 
different genetic backgrounds rather than from the 
worldwide spread of a single clone[12].
  Vancomycin has been the antibiotic of choice to treat 
MRSA infections, and the emergence of vancomycin-
nonsusceptible S. aureus reported in recent years is a cause 
of great public health concern and has made therapy of 
MRSA infections even more challenging for clinicians[7].
  Obtaining data about MRSA isolate and their pattern of 
resistance can be useful guideline for tropical infection 
control, antibiotic selection and more importantly to 
prognosis the resistant isolates in future. 
  The aim of this study is to determine the pattern of 
antibiotic resistance among S. aureus isolates from clinical 
specimens and to identify CA-MRSA in specimens that have 
been collected from patients referring to one of the hospitals 
of Ahvaz.
2. Materials and methods
2.1. Sample collection
  Bacterial strains were collected from October 2006 till 
May 2007 from patients that have been refereed to one 
of the hospitals of Ahvaz. The samples were collected 
from urine, blood and wound infection. After culturing 
and bacterial isolation, the isolates were identified by 
standard biochemical tests such as morphology of colony, 
gram staining, catalase reaction, oxidase reaction, growth 
on MRSA, mannitol fermentation, coagulase production, 
resistance to bacitracin and sensitivity to furazolidone. 
These isolates were suspended in skim milk (10%) 
suspension and stored at -20 曟, till antimicrobial resistance 
testing.
2.2. Antibiotic susceptibility test
  To determine the susceptibility of these isolates, a culture 
was prepared in trypticase soy broth (TSB, Merck) after 
thawing the suspensions and incubated at 37 曟 until 
reaching to turbidity equal to 0.5 Mc Farland turbidometer. 
A lawn culture was prepared from each isolate on Muller- 
Hinton Agar (Merck) and standard antibiotic discs with 
6 mm diameter including methicillin, cefixime, tylosine, 
tetracycline, trimethoprim/sulfamethoxazole, ciprofloxacine 
and norfloxacine were placed on the culture. The plates 
incubated at 37 曟 for 24h. After incubation, the average 
diameters of inhibition zone around each disc were 
recorded based on mm. The sensitivity of these isolates 
was determined by comparison of the above results with 
available data. 
2.3. Determining the genetic origin of resistance
  In order to determine if there was a plasmid responsible 
for resistance to methicillin or this trait was a chromosomal 
trait, ethidium bromide treatment was used for plasmid 
inactivation. This treatment would lead to plasmid 
elimination[13,14]. For this purpose 100 毺g/mL concentration 
of ethidium bromide was used[15]. The isolates that were 
resistant to methicillin were cultured in TSB and the above 
mentioned concentration of ethidium bromide was added to 
each tube. The cultures were incubated at 37 曟. After 24 h 
a culture was done from each tube on nutrient agar and after 
colony formation, one colony was transferred to Muller- 
Hinton broth. After reaching to 0.5 Mc Farland turbidity a 
lawn culture was prepared and methicillin discs were placed 
on the agar. Those isolates that were not able to grow in the 
presence of the methicillin were considered to be antibiotic 
resistance with plasmid origin.
3. Results
  Table 1 showed the results of antibiotic susceptibility 
testing. Among 83 samples cultured during this survey 
11 isolates of  S. aureus were collected and identified 
by standard biochemical tests. Then, the antibiotic 
susceptibility of these isolates was assessed. All of the S. 
aureus isolates were determined based on the inhibition 
zone diameter (mm) as methicillin resistant strains (resistance: 
≤ 9 mm, Intermediate: 9≤ inhibition≤14 mm, susceptible: 
14 mm). Then all of these isolates can be considered as MRSA 
and with regarding to that they were isolated from patients 
without any previous hospitalization were named as CA-
MRSA. Another finding was that all of these isolates were 
resistant to cefixime, a 毬-lactam antibiotic. This suggested 
that all of these isolates were 毬- lactamase producers and 
they may be resistant to other 毬- lactam antibiotics. Table 
1 showed that the majority of isolates were multi-resistant to 
other tested antibiotics. 
  All of 11 isolate resistant to methicillin were cured with 
ethidium bromide in order to find the genetical origin of 
resistance. After curing all of them were remained resistant 
to methicillin and did not inhibit by methicillin disc in 
second antibiotic susceptibility test. So it can be concluded 
that the origin of resistance in all of the S. aureus isolates in 
this survey was chromosomal.
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4. Discussion
  Since methicillin resistance emerged, MRSA has become 
widespread in hospitals worldwide, causing bacteremia, 
pneumonia, surgical site infections, and other nosocomial 
infections[16-20]. MRSA strains produce PBP2a that is not 
part of the intrinsic set of PBPs of S. aureus but is a unique, 
inducible, acquired protein that has a molecular weight of 
approximately 76 kDa, and it is produced only by methicillin 
resistant staphylococci[21]. PBP2a has low affinity for 毬
-lactam antibiotics and, therefore, is capable of substituting 
the biosynthetic functions of the normal PBPs even in 
the presence of the 毬-lactams, thereby preventing cell 
lysis. Isolates containing the PBP2a-mediated resistance 
mechanism are clinically resistant to all available 毬
-lactams, including penicillins, cephalosporins, 毬-lactam/
毬-lactamase inhibitor combinations, monobactams, and 
carbapenems[21,22]. PBP2a is encoded by the mecA gene, 
which is not present in methicillin susceptible strains, 
and it is believed to have been acquired from a distantly related 
species, although the exact origin has not been found yet[21, 23]. Bal 
et al[24] first sequenced mecA in 1987, and now it is known 
that this gene is carried on a mobile genetic element, the 
SCCmec[25]. In addition to carrying the mecA gene, the SCC 
contains regulatory genes, the IS431mec insertion sequence, 
and the recombinase genes ccr, which are responsible for 
the integration and excision of SCCmec[26]. The mec gene 
complex has been classified into four classes, and the ccr 
gene complex into three allotypes[23]. Different combinations 
of mec gene complex classes and ccr gene complex types 
have so far defined four types of SCCmec elements, labeled 
SCCmec types I-IV. With respect to the nature of these 
genetic elements responsible for resistance to methicillin, 
MRSA is increasingly grown and CA-MRSA will become more 
common. Most CA-MRSA isolates harboring SCCmec type IV 
are usually resistant to 毬-lactam and macrolide antibiotics, 
but susceptible to other classes[10]. Recently a novel type V 
SCCmec has been described in a CA-MRSA strain isolated in 
Australia[27].
  It is clear that the emergence of CA-MRSA isolates is 
changing the management of clinical infections potentially 
caused by S. aureus. So rapid methods for accurate detection 
of MRSA are necessary to promptly identify patients and 
implement contact precautions as well as appropriate 
treatment.
  Hence, survey is necessary for determining the rate of 
staphylococcus infections among different populations 
and also determining the source of resistance, plasmid or 
chromosome, is very important because plasmid resistance 
genes can more rapidly spread among bacterial isolate 
and cause rapid distribution of MRSA specially at hospital 
environments. 
  The results of this study revealed that S. aureus infection 
is widespread in patients referring to hospitals. All of the 
isolates were resistant to methicilin and with regard to 
the lack of any previous hospitalization in these patients, 
these strains can be named as CA- MRSA. The treatment 
of isolates with ethidium bromide showed that the genetic 
element responsible for resistance to methicilin was located 
on chromosome and plasmid did not have any role in this 
resistance. The plasmid mediated resistance can be rapidly 
spread specially in bacterial biofilms and health care 
centers. The occurrence of resistance to multiple antibiotics 
in the isolates in this study can be an alarm for infection 
treatment and can cause a major challenge for clinicians. 
Furthermore, these results necessitate continuous and 
regular monitoring and screening of S. aureus isolates 
from out-patients and as well as hospitalized patients for 
determining the prevalence of infection due to this agent, 
its antibiotic resistance pattern and finding appropriate 
antibiotic for treatment of these infections.  
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Table 1 
The susceptibility pattern of S. aureus isolates to common antibiotics (mm).       
Isolate
Antibiotics
SXT ME CP CFM TY T NFX
S83 23 0 28 0 20   0 32
           S5 19 0 29 0 24   0 32
           S2 13 0 31 0 22 25 31
S21 21 0 29 0 22 26 33
S11 26 0 33 0 25 24 34
S26   0 0   0 0   0   0 15
S76 25 0 18 0 15   0 20
S77   0 0 10 0 17   0 15
S73 22 0 34 0 28 16 33
S57 20 0 20 0 17 18 16
S29 26 0 17 0 15   0 17
Note: STX: Trimethoprim/Sulfamethoxazole, ME: Methicillin, CP: Ciprofloxacine, CFM: Cefixime, TY: Tylosine, T: Tetracycline, NFX: 
Norfloxacine.
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